Bibliographic Info
GuidelineWHO guidelines on hepatitis B and C testing.
Year of Publication2017
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Low
The use of (DRIED BLOOD SPOT) DBS specimens to test for HBV DNA for diagnosis of HBV viraemia, may be considered in settings where:
- there is a lack of access to sites or nearby laboratory facilities for nucleic acid testing (NAT), or
provision for timely delivery of specimens to a laboratory; or
- there are persons with poor venous access (e.g. in drug treatment
programmes, prisons).